Global Associate Director, Compound Market Access Leader - Oncology

Johnson & Johnson Innovative Medicine•Raritan, NJ

19h•$137,000 - $235,750•Onsite

About The Position

The Global Commercial Strategy Organization, a group within Janssen Global Services and a member of Johnson & Johnson's family of companies, is recruiting for an Associate Director, Global Market Access Strategy. This position will be based in Raritan, NJ. The Global Strategic Market Access Associate Director, reporting to the Senior Compound Market Access Leader (Sr CMAL), Early Pipeline & NBD, has a key role in helping the team develop and drive the market access strategy for the respective early assets, aligned with the global clinical and commercial strategy. In doing so, the Global Strategic Market Access Associate Director will help shape key strategic decisions through input/contributions to the Clinical Development and Evidence Generation Plans to ensure that strategic plans fully meet the needs of market access in key countries. The Global Strategic Market Access Associate Director must understand the needs of markets and support development of appropriate solutions.

Requirements

Master’s degree in appropriate field (Science, Economics, Biostatistics, Epidemiology, Health Economics, or Public Health) or a PharmD.
A minimum of 6 years in Health Economics and Outcomes Research or Market Access.
Market Access Landscape: The ability to shape the evolving payer landscape by researching, developing, and maintaining a deep understanding of payers and their perspectives in the key global markets. This includes knowledge of trends in pricing, reimbursement, healthcare policy, and all market archetypes.
Health Technology Assessment: Knowledge of the principles of evidence-based medicine and methodologies to evaluate health-related technology and deliver product dossiers.
Market Access Analytics: The ability to systematically gather and analyze information from various sources, including modeling, pricing, and contracting strategies. This includes the ability to generate data to support real-world evidence, identify and communicate patterns and trends, and evaluate and develop strategic plans.
Evidence Generation: The ability to apply data science concepts and methodologies to identify and articulate value propositions, create and implement value strategies, generate business insights, and drive evidence generation and debate on the appropriateness of conclusions. This includes providing market access inputs to clinical trial design, implementation, and analyses and knowledge of meta-analysis as well as epidemiologic studies.
Cross-Functional Teamwork
Evidence Generation
Market Access

Nice To Haves

Prior oncology experience
Demonstrated leadership experience in successfully working across functional and geographic boundaries, preferably across multiple countries/market types/access models
Therapeutic Area Knowledge: Knowledge of relevant therapeutic areas and targeted disease states to provide market access inputs into clinical trial design. This includes knowledge of portfolios, products, services, treatment options, associated clinical outcomes, understanding of patient flow, and the broader impact these variables have on market access strategies.
Clinical Trial Methodology: Knowledge of clinical trials and trial design. This includes applying knowledge to recommend study design plan and methodology, considering trade-offs of different approaches, and developing hypotheses to test primary versus secondary endpoints and implications for labeling.
Leadership Without Authority: The ability to utilize a deep understanding of internal and external stakeholder needs and perspectives to build collaborative partnerships, advocate for the value of market access strategies, and influence stakeholder decision making without authority. This includes taking ownership and being accountable to deliver key outcomes by engaging others and enabling alignment and discussion to ensure the right conclusions are captured.
Agility Jumps
Commercial Awareness
Competitive Landscape Analysis
Cross-Functional Collaboration
Customer Intelligence
Global Market
Go-to-Market Strategies
Health Economics
Health Intelligence
Market Knowledge
Market Opportunity Assessment
Mentorship
Organizing
Pricing Strategies
Regulatory Compliance
Strategic Change
Tactical Planning
Technical Credibility

Responsibilities

Support the Sr CMAL & CMALs in the team to maximize value across the early pipeline & NBD, including: Supporting assets and indications ahead of full investment in dedicated product teams, including assets prior to transition to full development, or additional indications outside current disease area strategy team remits.
Evaluation and strategic input into New Business Development opportunities to maximize deal value and support decision making.
Support the direction of work of cross functional teams, which includes the core functions within Global Maret Access (i.e., Health Economics, Patient Reported Outcomes [PRO], Access Policy, Pricing, Real-World Evidence & Analytics) to deliver the global market access strategy for the brand/asset.
Help design, develop and implement an integrated approach to all aspects of the payer value proposition from early development through to appointment of a dedicated product team for a complex portfolio of compounds and indications.
Support the early strategic planning and implementation of the payer value generation and access strategies.
Serve as a resource on access strategies and is a thought partner of the leaders of global clinical and commercial product teams, as well as disease area strategy groups
Support integration of pricing, payer research, health economic and epidemiology information to develop the optimal value strategy.
Support development of an integrated access strategy that reflects macro (health care reform, quality metrics, technology assessment) and disease specific (clinical profile, market segmentation, disease staging and clinical pathway) factors as well as the complexity of a companion diagnostic.
Provides support to ensure that clinical development programs fully capture the value of innovative products to payers, physicians and patients. This includes strategic advice to teams on patient populations, trial design, and selection of relevant endpoints.
Help drive the design and management of health outcomes studies including: systematic literature reviews, Real World Evidence studies, user-friendly cost effectiveness and budget impact models, where required, to support decision making or ensure launch readiness.
Support educating the commercial and R&D teams on key access trends and opportunities to shape their evolution.
Work with the Clinical Development Team (CDT) advising on market access data needs related to the clinical development plan; represent the access needs of the regions as the subject matter expert and advocate for the data necessary for positive reimbursement across global markets.
Support the management of market access discretionary budgets, ensuring the spending is managed effectively through the year and to plan.
Keep up to date with scientific developments, and environmental changes in pricing and reimbursement landscape to build the strongest possible value propositions.
Understand the patient perspective of the disease and recommend strategies that support the patient voice in key payer negotiations.
Ensure strategic alignment across region and countries: Support an engaged and collaborative Extended Market Access Team (EMAT), ensuring great communication and collaboration, sharing of best practice and co-creation.
Map the reimbursement pathways and funding mechanisms by key country.
To enable timely reimbursement and patient access, proactively support engagement with key external decision-makers to reach a consensus on acceptable evidentiary requirements.
Partner and co-lead with the region and country teams the preparation of deliverables for early scientific advice engagements.
Work with pricing colleagues to provide expert perspectives and establish pricing policies.
Foster collaboration, alignment, and seamless working across R&D and GCSO functions, including the Clinical Development Team (CDT), Commercial, Medical Affairs, and Global Market Access COE to ensure optimal launch readiness for the brand.

Benefits

Vacation –120 hours per calendar year
Sick time - 40 hours per calendar year; for employees who reside in the State of Colorado –48 hours per calendar year; for employees who reside in the State of Washington –56 hours per calendar year
Holiday pay, including Floating Holidays –13 days per calendar year
Work, Personal and Family Time - up to 40 hours per calendar year
Parental Leave – 480 hours within one year of the birth/adoption/foster care of a child
Bereavement Leave – 240 hours for an immediate family member: 40 hours for an extended family member per calendar year
Caregiver Leave – 80 hours in a 52-week rolling period
10 days Volunteer Leave – 32 hours per calendar year
Military Spouse Time-Off – 80 hours per calendar year
Annual performance bonus
Long-term incentive program